Autonomix Medical's Chief Medical Officer Honored with Cardiovascular Tech Forum Lifetime Achievement Award — Autonomix Medical, Inc.

Event summary

Autonomix Medical's Co-Founder & Chief Medical Officer Dr. Robert Schwartz received the 2026 Cardiovascular Tech Forum Lifetime Achievement Award.
Dr. Schwartz will be honored at Octane’s 2026 Cardiovascular Tech Forum on September 18, 2026, in Newport Beach, California.
Dr. Schwartz has authored over 500 scientific publications and holds more than 200 patents, including the co-invention of the Watchman device acquired by Boston Scientific.
Autonomix Medical is developing a catheter-based microchip sensing array for diagnosing and treating diseases involving the peripheral nervous system.

The big picture

The recognition of Dr. Robert Schwartz underscores the strategic importance of physician innovators in shaping cardiovascular and neuromodulation technologies. Autonomix Medical is positioning itself at the forefront of nerve-targeted treatments, aiming to address a broad spectrum of diseases beyond its initial focus on pancreatic cancer pain. The company's platform technology could disrupt traditional approaches to diagnosing and treating peripheral nervous system disorders.

What we're watching

Technology Validation: How Autonomix's nerve-targeted treatment platform will perform in initial trials for pancreatic cancer pain.
Market Expansion: The pace at which Autonomix can scale its technology across multiple indications, including cardiology and chronic pain management.
Leadership Impact: Whether Dr. Schwartz's leadership will accelerate Autonomix's mission to redefine peripheral nervous system treatments.